These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

991 related articles for article (PubMed ID: 15185901)

  • 1. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction and oxidative stress in chronic renal failure.
    Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
    J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function.
    Meyer C; Heiss C; Drexhage C; Kehmeier ES; Balzer J; Mühlfeld A; Merx MW; Lauer T; Kühl H; Floege J; Kelm M; Rassaf T
    J Am Coll Cardiol; 2010 Feb; 55(5):454-9. PubMed ID: 20117459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure.
    Matsumoto A; Hirata Y; Kakoki M; Nagata D; Momomura Si; Sugimoto T; Tagawa H; Omata M
    Clin Sci (Lond); 1999 Jan; 96(1):67-74. PubMed ID: 9857108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure.
    Scholze A; Rinder C; Beige J; Riezler R; Zidek W; Tepel M
    Circulation; 2004 Jan; 109(3):369-74. PubMed ID: 14732754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and comparison of endothelial function between dialysis and kidney transplant patients.
    Kocak H; Ceken K; Dinckan A; Mahsereci E; Yavuz A; Yucetin L; Akbas SH; Gurkan A; Erdogan O; Ersoy F; Yakupoglu G; Demirbas A; Tuncer M
    Transplant Proc; 2006 Mar; 38(2):416-8. PubMed ID: 16549135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction in patients with noncomplicated and complicated hypertension.
    Goch A; Banach M; Mikhailidis DP; Rysz J; Goch JH
    Clin Exp Hypertens; 2009 Feb; 31(1):20-30. PubMed ID: 19172456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension.
    Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Horio T; Yoshimasa Y; Harano Y
    Am J Hypertens; 2004 Mar; 17(3):228-32. PubMed ID: 15001196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function.
    Gresele P; Migliacci R; Vedovati MC; Ruffatti A; Becattini C; Facco M; Guglielmini G; Boscaro E; Mezzasoma AM; Momi S; Pengo V
    Thromb Res; 2009; 123(3):444-51. PubMed ID: 18617225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of renal transplantation on endothelial function in haemodialysis patients.
    Kocak H; Ceken K; Yavuz A; Yucel S; Gurkan A; Erdogan O; Ersoy F; Yakupoglu G; Demirbas A; Tuncer M
    Nephrol Dial Transplant; 2006 Jan; 21(1):203-7. PubMed ID: 16144848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.
    Mallamaci F; Benedetto FA; Tripepi G; Cutrupi S; Pizzini P; Stancanelli B; Seminara G; Bonanno G; Rapisarda F; Fatuzzo P; Malatino LS; Zoccali C
    J Hypertens; 2008 Sep; 26(9):1875-82. PubMed ID: 18698224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans.
    Kleinbongard P; Dejam A; Lauer T; Jax T; Kerber S; Gharini P; Balzer J; Zotz RB; Scharf RE; Willers R; Schechter AN; Feelisch M; Kelm M
    Free Radic Biol Med; 2006 Jan; 40(2):295-302. PubMed ID: 16413411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelial function in high risk cardiovascular patients].
    Káli A; Jánosi A
    Orv Hetil; 2006 Jan; 147(3):99-106. PubMed ID: 16515028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of haemodialysis on biochemical modulators of endothelial function.
    Hewitson CL; Whiting MJ; Barbara JA; Mangoni AA
    J Intern Med; 2007 Nov; 262(5):571-80. PubMed ID: 17949366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.
    Amabile N; Guérin AP; Leroyer A; Mallat Z; Nguyen C; Boddaert J; London GM; Tedgui A; Boulanger CM
    J Am Soc Nephrol; 2005 Nov; 16(11):3381-8. PubMed ID: 16192427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B; Anderstam B; Suliman M; Alvestrand A
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.